The present invention relates to the soluble glucan oligomer having a M.W.
ranging from 1,000 to 10,000 prepared by treating insoluble beta-glucan
isolated the cell wall of yeast variant IS2 with commercially available
beta-glucan hydrolyzing enzymes. The soluble glucan oligomer showed
potent efficacy on inhibiting activity of influenza virus and
transmissible gastroenteritis coronavirus, therefore, it can be used as
the therapeutics or health care food for treating and preventing mammal's
diseases caused by the infection of influenza virus and transmissible